BIANCHI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 25.402
EU - Europa 13.670
AS - Asia 13.457
SA - Sud America 2.149
Continente sconosciuto - Info sul continente non disponibili 659
AF - Africa 331
OC - Oceania 31
Totale 55.699
Nazione #
US - Stati Uniti d'America 24.769
FI - Finlandia 6.103
SG - Singapore 4.919
CN - Cina 3.630
IT - Italia 1.777
BR - Brasile 1.679
VN - Vietnam 1.367
DE - Germania 1.348
UA - Ucraina 1.071
HK - Hong Kong 1.039
PL - Polonia 926
TR - Turchia 702
GB - Regno Unito 695
FR - Francia 435
SE - Svezia 435
BD - Bangladesh 398
JP - Giappone 341
RU - Federazione Russa 316
CA - Canada 300
IN - India 284
MX - Messico 202
AR - Argentina 176
ID - Indonesia 173
NL - Olanda 148
ZA - Sudafrica 121
IQ - Iraq 97
CO - Colombia 85
ES - Italia 84
PK - Pakistan 71
BE - Belgio 67
EC - Ecuador 62
VE - Venezuela 49
LT - Lituania 48
MA - Marocco 46
PH - Filippine 46
IR - Iran 45
AT - Austria 43
UZ - Uzbekistan 43
MY - Malesia 39
CL - Cile 37
SA - Arabia Saudita 35
EG - Egitto 34
PY - Paraguay 30
AE - Emirati Arabi Uniti 29
AU - Australia 29
CZ - Repubblica Ceca 28
JM - Giamaica 27
KE - Kenya 27
TN - Tunisia 27
CH - Svizzera 22
CR - Costa Rica 20
JO - Giordania 20
KR - Corea 19
NP - Nepal 17
RO - Romania 15
DZ - Algeria 14
HN - Honduras 14
IL - Israele 14
PT - Portogallo 14
AZ - Azerbaigian 13
ET - Etiopia 12
GR - Grecia 12
IE - Irlanda 12
LB - Libano 12
PE - Perù 12
PS - Palestinian Territory 12
TH - Thailandia 12
GT - Guatemala 11
BO - Bolivia 10
TW - Taiwan 10
KW - Kuwait 9
KZ - Kazakistan 9
LV - Lettonia 9
NG - Nigeria 9
PA - Panama 9
AL - Albania 8
BH - Bahrain 7
NI - Nicaragua 7
OM - Oman 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
EU - Europa 6
GA - Gabon 6
KG - Kirghizistan 6
MD - Moldavia 6
PR - Porto Rico 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
UY - Uruguay 6
BB - Barbados 5
EE - Estonia 5
GE - Georgia 5
HU - Ungheria 5
LY - Libia 5
SY - Repubblica araba siriana 5
BG - Bulgaria 4
CG - Congo 4
CI - Costa d'Avorio 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 54.965
Città #
Helsinki 5.751
Singapore 3.077
Ashburn 2.862
San Jose 1.940
Woodbridge 1.919
Fairfield 1.705
Beijing 1.305
Chandler 1.186
Jacksonville 1.186
Houston 1.151
Ann Arbor 1.111
Santa Clara 1.037
Hong Kong 1.019
Warsaw 896
Council Bluffs 823
Seattle 709
Wilmington 674
Cambridge 578
New York 554
Dallas 471
Ho Chi Minh City 447
Los Angeles 402
Nanjing 396
Izmir 384
Ferrara 380
Hanoi 352
Munich 349
Tokyo 316
Princeton 277
Lauterbourg 243
Boardman 201
Milan 197
Bremen 172
Shanghai 155
São Paulo 152
San Diego 147
Bologna 127
Orem 119
Mexico City 117
Shenyang 117
Toronto 106
Turku 105
Nanchang 102
Jakarta 101
Addison 100
London 96
Buffalo 92
Chicago 92
Phoenix 85
Tianjin 79
Hefei 77
Hebei 75
Frankfurt am Main 73
Brooklyn 71
Denver 71
Atlanta 70
Montreal 69
Rome 68
Changsha 67
Chennai 67
Johannesburg 66
Brussels 63
Redwood City 63
Stockholm 62
Rio de Janeiro 60
Falls Church 59
Falkenstein 57
Haiphong 57
Da Nang 56
Jiaxing 56
San Francisco 56
The Dalles 55
Moscow 54
Mountain View 48
Amsterdam 45
Jinan 45
Poplar 43
Zhengzhou 43
Dearborn 42
Guangzhou 41
Ningbo 39
Belo Horizonte 37
Boston 36
Mumbai 36
Dhaka 35
Baghdad 34
Manchester 34
Tashkent 34
Norwalk 33
San Mateo 33
Columbus 31
Brasília 30
Dong Ket 30
Auburn Hills 28
Vienna 28
Washington 28
Des Moines 27
Philadelphia 27
Curitiba 26
Nuremberg 26
Totale 38.373
Nome #
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.981
Nuovo impiego di poliammidi eterocicliche e benzoeterocicliche strutturalmente correlate all'antibiotico naturale Distamicina A 1.974
SYNTHETIC OLIGONUCLEOTIDES AS INDUCERS OF ERYTHROID DIFFERENTIATION 1.973
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 541
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 425
A validated cellular biobank for β-thalassemia 422
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 388
Pyrazolo-triazoles as light activable dna cleaving agents 381
A validated THALAMOSS cellular biobank for β-thalassemia 352
Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports 318
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 317
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 310
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 303
Drug repurposing and transposable elements: a new promising strategy to fight prostate cancer 295
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 290
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 274
Analytic and dynamic secretory profile of patient-derived cytokine-Induced killer cells 266
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 265
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 264
Alteration of the expression of human estrogen receptor gene by distamycin 263
Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells 263
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 263
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 256
Possible detection of Autologous Blood Transfusion (ABT) based on circulating plasma microRNAs involved in erythroid differentiation and fetal hemoglobin induction 253
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 252
Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport 251
A chromatographic procedure for fully automated isolation of DNA from human whole blood 248
Spotlight on the transglutaminase 2 gene: A focus on genomic and transcriptional aspects 248
A non-radioactive automated protocol to study protein-DNA interactions by DNase I footprinting 247
Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors 245
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 244
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 242
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 240
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 238
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 233
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 233
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 232
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 231
A liquid biopsy model: Circulating miRNA levels in mice bearing colorectal carcinoma tumor xenografts 231
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 231
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 231
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 230
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 228
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 228
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 227
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 226
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 225
Somatic and germline variants affect prognosis and susceptibility in prostate cancer 224
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 223
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 223
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 222
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 221
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 220
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 218
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 218
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 217
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 214
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 214
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 214
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 214
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 213
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 213
Regulation of IL-8 gene expression in gliomas by microRNAs 211
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 211
Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer 211
Structure and Biological Activity of Furocoumarins 209
Liposomes as carriers for DNA-PNA hybrids 208
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 205
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 205
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 204
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 202
Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study 202
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 202
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 201
Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes 201
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 201
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 200
Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism. 199
Cellular biosensors for the identification of fetal hemoglobin inducers 198
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 198
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 197
Induction of erythroid differentiation of human K562 cells by cisplatin analogs 197
Plants with antitumor properties:from biologically active molecules to drugs 196
Alteration of microRNA biological activity with peptide nucleic acid 196
Sequencing of an RNA transcript of the human estrogen receptor gene: evidence for a new transcriptional event. 196
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 195
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 195
Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions 195
Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction 195
Capillary electrophoresis: detection of hybridization between synthetic oligonucleotides and HIV-1 genomic DNA amplified by polymerase-chain reaction 194
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 194
Inhibition of miRNA Maturation by Peptide Nucleic Acids. 194
In vitro and in vive binding of a CC-1065 analogue to human gene sequences: A polymerase-chain reaction study 192
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 191
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 190
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 188
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 188
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 187
Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin 187
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 186
Totale 28.867
Categoria #
all - tutte 229.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.769
Totale 233.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.141 0 0 115 90 167 163 95 124 81 261 308 737
2022/20232.754 290 208 86 354 526 398 117 239 283 19 142 92
2023/20241.960 130 205 62 52 140 383 97 319 18 33 80 441
2024/20256.722 206 240 569 329 696 549 258 387 1.052 784 913 739
2025/202623.622 1.626 775 1.577 2.268 2.504 1.161 2.143 1.060 7.240 2.054 779 435
2026/20272.516 570 977 969 0 0 0 0 0 0 0 0 0
Totale 55.699